Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-11451-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 24.01.2026. Verfasst von Shaza M Mohamedahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Sunway, 475000, Selangor, Malaysia. Hauptthemen laut MEDLINE: Spheroids, Cellular, Triple Negative Breast Neoplasms, Cell Culture Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.
Abstract (Originalsprache)
Purpose
Three-dimensional (3D) spheroid models are increasingly used to emulate the tumour microenvironment for preclinical drug screening. This study aimed to optimise and assess spheroid formation from MDA-MB-468 triple-negative breast cancer (TNBC) cells using hanging drop, liquid overlay, and rigid scaffold methods under normal oxygen (NOC) and low oxygen (LOC) culture conditions.
Methods
Spheroids were generated and characterised using bright-field microscopy with AnaSP morphometrics (sphericity, solidity, and perimeter). Gene expression of Epithelial-Mesenchymal Transition (EMT), stemness, and hypoxia/angiogenesis markers (CD44, HIF1A, VEGFA, TWIST1, SNAI1, and NES) was quantified using qPCR. The optimised model was further evaluated using field-emission scanning electron microscopy (FE-SEM) and Hoechst fluorescence.
Results
A workflow combining hanging-drop pre-aggregation with ultra-low attachment (ULA) or agarose-coated plates under NOC produced consistent, compact spheroids. Scaffold cultures formed rapidly but showed size variability under NOC and LOC. Across methods, spheroids were less compact, and gene expression patterns deviated from expected hypoxic responses. HIF1A and VEGFA were more highly expressed under NOC, suggesting pseudo-hypoxic signalling and activation of angiogenesis-related pathways. CD44 and TWIST1 were upregulated in most spheroid types, whereas SNAI1 and NES exhibited condition- and method-specific variability.
Conclusion
Spheroids cultivated under normoxic conditions demonstrated enhanced structural integrity and transcriptional fidelity. Nonetheless, the study identified that the most compact and resilient spheroids were achieved through the use of hanging-drop pre-aggregation combined with ULA-plates under NOC. The enhanced structural integrity and transcriptional fidelity observed in these spheroids make them valuable models for studying cancer biology and drug responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Sunway, 475000, Selangor, Malaysia.
- School of Pharmacy, Monash University Malaysia, Sunway, 47500, Selangor, Malaysia.
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Sunway, 475000, Selangor, Malaysia. ammu.radhakrishnan@monash.edu.
Förderung
- Monash University
Zitieren
APA
Mohamedahmed, S. M., Kamarudin, M. N. A., Ramdas, P., Sundralingam, U., & Radhakrishnan, A. K. (2026). Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-11451-4
Vancouver
Mohamedahmed SM, Kamarudin MNA, Ramdas P, Sundralingam U, Radhakrishnan AK. Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-11451-4
BibTeX
@article{Mohamedahmed2026,
author = {Mohamedahmed, Shaza M and Kamarudin, Muhamad Noor Alfarizal and Ramdas, Premdass and Sundralingam, Usha and Radhakrishnan, Ammu K},
title = {Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-11451-4}
}
EUVIMED